SETD2 and nonpapillary renal cell carcinoma: Thus, our experimental evidences reveal that SETD2 plays an important role in regulating ccRCC cell proliferation and apoptosis, and loss of SETD2 affords for the miR-106b-5p-mediated oncogenic role.